Nosocomial transmission of Cupriavidus pauculus during extracorporeal membrane oxygenation

ASAIO J. 2010 Sep-Oct;56(5):486-7. doi: 10.1097/MAT.0b013e3181f0c80d.

Abstract

Patients undergoing extracorporeal membrane oxygenation (ECMO) are at increased risk of infection. We present the first known report of nosocomial infection with Cupriavidus pauculus attributable to contamination from ECMO equipment and describe the measures taken to halt subsequent infections. A cluster of infections in ECMO patients should prompt team members to consider contamination of equipment with environmental pathogens as a possible cause.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cefepime
  • Cephalosporins / therapeutic use
  • Child, Preschool
  • Ciprofloxacin / therapeutic use
  • Cross Infection / drug therapy
  • Cross Infection / microbiology*
  • Cupriavidus
  • Equipment Contamination*
  • Extracorporeal Membrane Oxygenation / adverse effects*
  • Gentamicins / therapeutic use
  • Gram-Negative Bacterial Infections / drug therapy
  • Gram-Negative Bacterial Infections / etiology*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Meropenem
  • Penicillanic Acid / analogs & derivatives
  • Penicillanic Acid / therapeutic use
  • Piperacillin / therapeutic use
  • Tazobactam
  • Thienamycins / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Gentamicins
  • Thienamycins
  • Ciprofloxacin
  • Cefepime
  • Penicillanic Acid
  • Meropenem
  • Tazobactam
  • Piperacillin